06/14/22 2:00 PMNasdaq : ADTX covid-19Premier Medical Laboratory Services Now Offering AditxtScore™ Personalized Immune Test for COVID-19Premier Medical Laboratory Services (PMLS), a nation leading advanced medical diagnostics lab, adds AditxtScore™ to its menu of testing services. Providing more clarity regarding a patient's individual immunity profile, AditxtScore™ allows patientsRHEA-AIneutral
04/14/22 9:00 AMNasdaq : ADTX partnershipAditxt, Inc. Partners with Guthy-Renker Affiliate GRS to Launch Consumer Awareness Campaign for AditxtScore™ to Accelerate Adoption and Revenue GrowthAditxt, Inc., a biotech innovation company developing technologies focused on mapping and reprogramming the immune system, today is announcing a multiyear partnership with GRS, an affiliate of marketing powerhouse Guthy-Renker, LLC. Aditxt plans to work with GRS to produce and subsequently air AditxtScore™ TV commercials in order to help set the stage for an...RHEA-AIvery positive
04/05/22 8:30 AMNasdaq : ADTX Aditxt Signs Revenue-Sharing Agreement with Cellvera for up to $30M, and Hosts a Live Business Update Webinar on April 14thAditxt, Inc. has entered into a revenue-sharing agreement with Cellvera, and certain of its affiliates. Under the terms of the agreement, Aditxt will receive up to 10% of net sales of products and services collected by Cellvera and other loan parties up to a maximum of $30 million. Aditxt has agreed to apply approximately the first $14.5 million of the revenue...RHEA-AIpositive
03/23/22 8:30 AMNasdaq : ADTX conferencesAditxt to Participate in the 2022 Virtual Growth ConferenceAditxt, Inc., a biotech innovation company developing technologies focused on mapping and reprogramming the immune system, announced today that Company CEO& Co-Founder, Amro Albanna, has been invited to present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, on March 28th- 30th from 9:00 a.m.- 5:00 p.m. EDT.RHEA-AIneutral
01/18/22 8:30 AMNasdaq : ADTX covid-19Aditxt Submits Two Requests for Emergency Use Authorization to FDA for AditxtScore™ for COVID-19 Tests Which Measure the Quantity and Quality of Antibodies Against COVID-19 and its Variants Including OmicronAditxt, Inc., a biotech innovation company with a mission to advance humanity’ s transition to the“ Age of Immunity,” has submitted two EUA applications for AditxtScore™ for COVID-19. In mid-2021, Aditxt launched a high complexity, Clinical Laboratory Improvement Amendments certified AditxtScore™ Immune Monitoring Center in Richmond, Virginia.RHEA-AIneutral
01/14/22 9:00 AMNasdaq : ADTX conferencesAditxt, Inc. to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference From January 25th-27th, 2022Aditxt, Inc. announced today it is participating in Edison Group’ s Open House Event, scheduled to take place virtually this month. The three-day event, in association with the London Stock Exchange, global law firm Taylor Wessing, and OpenExchange, will take place between January 25 th -27 th, focusing on 33 companies. Edison Group: Global Healthcare Open House...RHEA-AIneutral
01/12/22 9:00 AMNasdaq : ADTX Aditxt Provides Online Business Update Townhall Meeting with Amro Albanna, Co-Founder & CEOAditxt, Inc., a biotech innovation company with a mission to improve the health of the immune system, today announced it will host an online business update townhall meeting with Amro Albanna, Co-Founder& CEO on Tuesday, January 18 th from 2:00 to 3:00 pm ET. The upcoming meeting will include, but is not limited to, commentary on the following topics:.RHEA-AIneutral
12/29/21 9:06 AMNasdaq : ADTX Aditxt Signs Amendment to Extend Worldwide Licensing Agreement, Granting Exclusivity in all Fields of UseAditxt, Inc., a biotech innovation company with a mission to improve the health of the immune system, today announced it had signed an amendment to its February 3, 2020, Exclusive License Agreement with Stanford University, extending Aditxt’ s exclusive right to license the technology deployed in AditxtScore™ and securing worldwide exclusivity in all fields...RHEA-AIvery positive
12/28/21 9:00 AMNasdaq : ADTX acquisitionAditxt Signs Share Exchange Agreement to Acquire AiPharmaAditxt Inc., a biotech innovation company with a mission to improve the health of the immune system, has signed a share exchange agreement to acquire AiPharma Global Holdings LLC, a wholly-owned subsidiary of AiPharma Group Ltd.. First, an initial closing is expected to occur upon the satisfaction of certain conditions no later than January 31, 2022, at which...RHEA-AIneutral
12/13/21 8:44 AMNasdaq : ADTX acquisitionAditxt, Inc. Signs Non-Binding Letter of Intent to Acquire Point-of-Care Diagnostic Technology Development CompanyAditxt, Inc., a biotech innovation company with a mission to improve the health of the immune system, today announced it had signed a non-binding letter of intent to acquire a company focused on developing Point-of-Care diagnostics for early detection of diseases including cancers and SARS-CoV-2 through a range of non-invasive and affordable point of care...RHEA-AIvery positive